タグ: PelvicOrganProlapse

Laparoscopic Sacrocolpopexy (LSC): Now Possible with Just a 2-Night Hospital Stay

3月 29th, 2025

Pelvic organ prolapse (POP) surgery is becoming more accessible than ever

For a long time, laparoscopic sacrocolpopexy (LSC)—a commonly performed surgery for pelvic organ prolapse—required a hospital stay of about one week. This extended hospitalization was often a barrier for many women balancing busy lives and family responsibilities.

However, things are changing.

LSC in Just 2 Nights, 3 Days

Today, some medical institutions in Japan now offer LSC with a 2-night, 3-day hospital stay, thanks to medical advancements and streamlined surgical care.

Hospitals currently providing short-stay LSC include:

• Kameda Medical Center, Department of Female Urology

• Awa Regional Medical Center

• Yotsuya Medical Cube

Here’s what the typical schedule looks like:

• Kameda and Awa Center:

Day 1 – Admission

Day 2 – Surgery, Catheter removal

Day 3 – Discharge

• Yotsuya Medical Cube:

Day 1 – Admission & Surgery

Day 2 – Catheter removal

Day 3 – Discharge

Why Not Shorter, Like Day Surgery?

Technically, it is possible to do LSC as a 1-night or even same-day procedure.

However, due to the need for pre-op orientation, testing, nursing assessments, and administrative procedures, shorter hospital stays can be difficult to implement in large hospital systems.

Safer Anesthesia and Faster Recovery

The shift toward shorter stays has been driven by safer general anesthesia and the use of laparoscopic (minimally invasive) techniques.

For example, laparoscopic inguinal hernia surgeries are now often performed as outpatient procedures, with patients going home the same day.

LSC, being similar in nature, is also heading in this direction.

Moreover, many institutions are now introducing ERAS (Enhanced Recovery After Surgery) protocols, which focus on reducing post-operative discomfort and helping patients recover faster and more comfortably.

Could Same-Day LSC Be the Future?

With ongoing medical innovation and thoughtful perioperative management, same-day discharge after LSC may one day become a reality.

This is exciting news for women who may have postponed surgery due to time or scheduling concerns.

Bringing Surgery Closer to Everyday Life

The traditional view that “surgery means long hospital stays and a lot of hassle” is being rewritten.

Women juggling work, family, and personal time no longer need to give up on treatment for pelvic organ prolapse.

We’re entering a new era where surgery is more accessible, efficient, and patient-centered.

If you’ve been putting off care because “there’s just no time,” you might be surprised to find that treatment is now much more convenient.

#PelvicOrganProlapse

#LSC

#Sacrocolpopexy

#MinimallyInvasiveSurgery

#FemaleUrology

#Urogynecology
When Vaginal Pain Isn’t Just GSM: A Case of Mesh Exposure After RASC

3月 28th, 2025

Today, a patient visited us for follow-up after undergoing native tissue repair (NTR) due to painful vaginal mesh exposure.

This patient had previously undergone robot-assisted laparoscopic sacrocolpopexy (RASC) for pelvic organ prolapse. After surgery, she began experiencing vaginal pain and sought help at a local women’s clinic. There, she was diagnosed with genitourinary syndrome of menopause (GSM) and underwent three sessions of vaginal laser therapy.

However, rather than improving, her pain worsened. Concerned and anxious, she came to our clinic for a second opinion.

Upon examination using speculum and endoscopic inspection, we discovered mesh exposure inside the vagina accompanied by infection—a finding that explained her persistent pain.

It is important to note that applying laser treatment to an infected mesh site may worsen symptoms. In this case, the true cause of the pain wasn’t GSM but a complication from the mesh. The right treatment wasn’t more laser—it was mesh removal and reconstruction using native tissue.

We performed laparoscopic mesh excision and NTR. Her recovery was smooth, and after the inflammation subsided, we proceeded with carefully adjusted Intima laser therapy (3 sessions).

The results were remarkable:

Her vaginal pH improved from 8.0 to 4.5, and her pain significantly decreased, leading to a noticeable improvement in her quality of life.

Key Takeaway:

Not all vaginal pain in postmenopausal women is GSM.

If we hastily assume GSM without thorough evaluation, we may miss the true underlying cause.

Diagnosis and the order of treatment matter.

Vaginal mesh exposure, especially when infected, is a serious complication that requires careful assessment and individualized treatment planning.

If you’re experiencing:

• Persistent pain after laser therapy

• Worsening symptoms instead of improvement

• A sense of foreign body or unusual discharge from the vagina

Don’t hesitate—seek expert evaluation early.

タグ: PelvicOrganProlapse

Laparoscopic Sacrocolpopexy (LSC): Now Possible with Just a 2-Night Hospital Stay

When Vaginal Pain Isn’t Just GSM: A Case of Mesh Exposure After RASC